-
Listing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystem更多Seamless listing, trading, clearing and settlement for fixed income
-
Trading
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystem更多
Seamless listing, trading, clearing and settlement for fixed income
-
Clearing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystem更多
Seamless listing, trading, clearing and settlement for fixed income
-
CSD
European CSD modelBuilding the CSD of Choice in Europe更多Euronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)更多The new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperNext generation of indices更多This white paper marks the second edition of Euronext’s Index Outlook series, a recurring publication designed to give investors deeper insight into our index innovation agenda and the structural forces shaping global markets.
-
About Euronext
IPO Biophytis
16/07/2015
EnterNext welcomes Biophytis on Alternext in Paris
Stanislas Veillet, CEO and co-founder of Biophytis, rings the opening bell.
Biophytis specializes in the development of nutraceuticals and drugs with active phytonutriments for the treatment of metabolic and aging diseases.
The company has a portfolio of 2 nutraceutical assets in clinical phase (Quinolia for the treatment of obesity and Bixilia for the protection of the skin from UV rays) and drug candidates in preclinical phase (treatment of sarcopenic obesity and age-related macular degeneration).